Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HTLV-1 Adult T-cell Lymphoma / Leukemia”

28 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 28 results

Not applicableStudy completedNCT03146013
What this trial is testing

Dual Algorithm Post Market Clinical Study

Who this might be right for
HTLV-I InfectionsHTLV-II InfectionsHuman T-lymphotropic Virus 1+3 more
MP Biomedicals, LLC 100
Testing effectiveness (Phase 2)Ended earlyNCT03075553
What this trial is testing

Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

Who this might be right for
Blastic Plasmacytoid Dendritic Cell NeoplasmHepatosplenic T-Cell LymphomaHTLV-1 Infection+14 more
Mayo Clinic 12
Testing effectiveness (Phase 2)Ended earlyNCT00117845
What this trial is testing

Phase II Study of the Efficacy and Toxicity of Ontak(Registered Trademark) (Denileukin Diftitox) in the Therapy of Adult T-Cell Leukemia

Who this might be right for
Leukemia, Adult T-Cell
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Study completedNCT02631746
What this trial is testing

Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma

Who this might be right for
Acute Adult T-Cell Leukemia/LymphomaAdult T-Cell Leukemia/LymphomaChronic Adult T-Cell Leukemia/Lymphoma+3 more
National Cancer Institute (NCI) 3
Not applicableStudy completedNCT01941680
What this trial is testing

High Risk Adult T-cell Leukemia/Lymphoma (ATLL-HR) and Allogeneic Transplant

Who this might be right for
T-cell LymphomaLeukaemia
University Hospital Center of Martinique 20
Early research (Phase 1)Temporarily pausedNCT04301076
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)

Who this might be right for
Acute Adult T-Cell Leukemia/LymphomaAdult T-Cell Leukemia/LymphomaChronic Adult T-Cell Leukemia/Lymphoma+1 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT01274533
What this trial is testing

Lenalidomide in HTLV-1 Adult T-Cell Leukemia

Who this might be right for
Adult T Cell Leukemia/Lymphoma
Columbia University 4
Testing effectiveness (Phase 2)Study completedNCT00061048
What this trial is testing

Campath-1H for Treating Adult T-Cell Leukemia/Lymphoma

Who this might be right for
Acute T-Cell Leukemia-Lymphoma
National Cancer Institute (NCI) 29
Post-approval studies (Phase 4)Study completedNCT01418430
What this trial is testing

Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab)

Who this might be right for
HTLV-I Associated Adult T-cell Leukaemia/Lymphoma (ATLL)
King's College Hospital NHS Trust
Testing effectiveness (Phase 2)Ended earlyNCT04362007
What this trial is testing

A Phase I/II Study of ASTX660 in Patients With Relapsed or Refractory T-cell Lymphoma

Who this might be right for
Relapsed or Refractory Peripheral T-cell Lymphoma(PTCL),Cutaneous T-cell Lymphoma(CTCL),Adult T-cell Leukemia/Lymphoma(ATLL)
Otsuka Pharmaceutical Co., Ltd. 8
Testing effectiveness (Phase 2)WithdrawnNCT01620736
What this trial is testing

Trial to Assess Effect of Raltegravir on HTLV-1 Proviral Load

Who this might be right for
Human T-cell Leukemia Virus Type 1 Infection
Washington University School of Medicine
Testing effectiveness (Phase 2)Study completedNCT01000285
What this trial is testing

EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma

Who this might be right for
Leukemia-Lymphoma, Adult T-Cell
Washington University School of Medicine 18
Early research (Phase 1)Study completedNCT02580552
What this trial is testing

Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL

Who this might be right for
Cutaneous T-cell Lymphoma (CTCL)Mycosis Fungoides (MF)Chronic Lymphocytic Leukemia (CLL)+2 more
miRagen Therapeutics, Inc. 66
Testing effectiveness (Phase 2)Ended earlyNCT01712659
What this trial is testing

Ruxolitinib for Adult T-Cell Leukemia

Who this might be right for
T Cell Leukemia, AdultLeukemia, Adult T-CellT Cell Leukemia, HTLV I Associated
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Study completedNCT00001941
What this trial is testing

Anti-Tac for Treatment of Leukemia

Who this might be right for
HTLV-I InfectionT Cell Leukemia
National Cancer Institute (NCI) 34
Post-approval studies (Phase 4)Ended earlyNCT00854581
What this trial is testing

Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma

Who this might be right for
LymphomaPrecancerous/Nonmalignant Condition
University of Miami 13
Not applicableActive Not RecruitingNCT05237245
What this trial is testing

Clinico-biological Characterization and Survival of Patients With Adult T-cell Leukemia / Lymphoma (ATL) and Patients Chronically Infected With the HTLV-1 Virus (HTLV-OBS)

Who this might be right for
Lymphoproliferation Induced by HTLV-1HTLV-1 Adult T-cell Lymphoma / LeukemiaHTLV-1 Infection
Assistance Publique - Hôpitaux de Paris 69
Testing effectiveness (Phase 2)Looking for participantsNCT06698003
What this trial is testing

Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1

Who this might be right for
T-Cell Leukemia/Lymphoma, AdultT-cell Leukemia/LymphomaT-cell Leukemia+1 more
Memorial Sloan Kettering Cancer Center 134
Early research (Phase 1)Study completedNCT01169298
What this trial is testing

A Phase I, Multicenter, Open-label, Dose-escalation Study to Assess the Safety of Lenalidomide in Patients With Advanced Adult T-cell Leukemia-lymphoma and Peripheral T-cell Lymphomaperipheral T-cell Lymphoma

Who this might be right for
Adult T-cell Leukemia-LymphomaPeripheral T-cell Lymphoma
Celgene 13
Not applicableStudy completedNCT00340821
What this trial is testing

Familial and Genetic Aspects of Adult T-Cell: Leukemia/Lymphoma , Tropical Spastic Paraparesis, and Infective Dermatitis

Who this might be right for
HTLV-I
National Cancer Institute (NCI) 1,800
Load More Results